Status:
ACTIVE_NOT_RECRUITING
Clinical Efficacy and Molecular Dynamics of Quantum Molecular Resonance (QMR) Electrotherapy in Dry Eye Management
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Dry Eye Disease (DED)
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This project aims to investigate the clinical efficacy and molecular mechanisms of Quantum Molecular Resonance (QMR) electrotherapy in the management of dry eye disease (DED). DED is a multifactorial ...
Detailed Description
Study Purpose and Potential Benefits: Recently, a high frequency electrotherapy device using Quantum Molecular Resonance (QMR) technique, the Rexon-Eye was being developed for dry eye treatment. Duri...
Eligibility Criteria
Inclusion
- aged 18 to 40 years old
- with habitual or best corrected visual acuity better than or equal to 6/9
- diagnosed as dry eye disease according to OSDI score (13 or above) and at least one positive result from dry eye assessment.
Exclusion
- history of ocular inflammation, trauma or surgery within 6 months
- long-term ocular medications
- current dry eye treatment
- uncontrolled, newly diagnosed systemic diseases
- with modified long-term medications within 6 months that are known to affect tear profile
- carrying active implantable devices (e.g., pacemakers and hearing aids)
Key Trial Info
Start Date :
May 31 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06955806
Start Date
May 31 2025
End Date
December 31 2026
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hong Kong, Hong Kong